Mersana Therapeutics (MRSN) Short Interest Ratio & Short Volume → Truth about Trump you’ve never heard (From Porter & Company) (Ad) Free MRSN Stock Alerts $2.61 -0.01 (-0.38%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mersana Therapeutics Short Interest DataCurrent Short Volume10,920,000 sharesPrevious Short Volume10,580,000 sharesChange Vs. Previous Month+3.21%Dollar Volume Sold Short$34.62 millionShort Interest Ratio / Days to Cover5.0Last Record DateApril 30, 2024Outstanding Shares122,361,000 sharesPercentage of Shares Shorted8.92%Today's Trading Volume5,056,411 sharesAverage Trading Volume2,168,159 sharesToday's Volume Vs. Average233% Short Selling Mersana Therapeutics ? Sign up to receive the latest short interest report for Mersana Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatMRSN Short Interest Over TimeMRSN Days to Cover Over TimeMRSN Percentage of Float Shorted Over Time Ad Banyan Hill PublishingForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadThe AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. Mersana Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202410,920,000 shares $34.62 million +3.2%N/A5 $3.17 4/15/202410,580,000 shares $40.10 million +4.4%N/A4.8 $3.79 3/31/202410,130,000 shares $45.38 million +16.0%N/A4.3 $4.48 3/15/20248,730,000 shares $44.00 million +22.3%N/A3.8 $5.04 2/29/20247,140,000 shares $38.84 million +0.6%N/A3.4 $5.44 2/15/20247,100,000 shares $27.26 million +6.8%N/A3.6 $3.84 Get the Latest News and Ratings for MRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mersana Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20246,650,000 shares $21.01 million -10.0%N/A3.5 $3.16 1/15/20247,390,000 shares $22.32 million -11.9%N/A3.6 $3.02 12/31/20238,390,000 shares $19.46 million -0.8%N/A4.1 $2.32 12/15/20238,460,000 shares $17.34 million -28.7%N/A4.3 $2.05 11/30/202311,870,000 shares $19.59 million -13.9%N/A5.4 $1.65 11/15/202313,790,000 shares $21.24 million +22.3%N/A6.6 $1.54 10/31/202311,280,000 shares $13.42 million +0.1%N/A5.2 $1.19 10/15/202311,270,000 shares $17.47 million +10.5%N/A1.7 $1.55 9/30/202310,200,000 shares $12.95 million -10.7%N/A1.6 $1.27 9/15/202311,420,000 shares $16.22 million +8.4%N/A1.8 $1.42 8/31/202310,540,000 shares $11.70 million -13.0%N/A1.4 $1.11 8/15/202312,120,000 shares $15.27 million -9.5%N/A1.7 $1.26 7/31/202313,390,000 shares $16.40 million +118.8%N/A1.8 $1.23 7/15/20236,120,000 shares $22.34 million -3.0%N/A1.9 $3.65 6/30/20236,310,000 shares $20.76 million +26.0%N/A2 $3.29 6/15/20235,010,000 shares $19.49 million -14.8%N/A1.7 $3.89 5/31/20235,880,000 shares $44.22 million -9.4%N/A3.1 $7.52 5/15/20236,490,000 shares $51.60 million -11.6%N/A3.6 $7.95 4/30/20237,340,000 shares $32.15 million +1.1%N/A4.3 $4.38 4/15/20237,260,000 shares $30.13 million -0.6%N/A5.8 $4.15 3/31/20237,300,000 shares $30.00 million +16.6%N/A5.6 $4.11 3/15/20236,260,000 shares $28.48 million -10.3%N/A4.8 $4.55 2/28/20236,980,000 shares $42.30 million +20.1%N/A5.9 $6.06 2/15/20235,810,000 shares $36.95 million +1.9%N/A5.1 $6.36 1/31/20235,700,000 shares $37.51 million +9.2%N/A5.2 $6.58 1/15/20235,220,000 shares $31.63 million +3.6%N/A4.8 $6.06 12/30/20225,040,000 shares $29.53 million +11.8%N/A4.8 $5.86 12/15/20224,510,000 shares $31.12 million -5.1%N/A4.4 $6.90 11/30/20224,750,000 shares $31.64 million +0.4%N/A4.7 $6.66 11/15/20224,730,000 shares $32.73 million -12.4%N/A4.5 $6.92 10/31/20225,400,000 shares $42.44 million -6.3%N/A4.9 $7.86 10/15/20225,760,000 shares $37.90 million +7.9%N/A4.2 $6.58 9/30/20225,340,000 shares $36.10 million +38.0%N/A3.9 $6.76 9/15/20223,870,000 shares $29.57 million +8.4%N/A2.7 $7.64Forget the “Magnificent 7” Tech Companies, Buy This AI Stock Instead (Ad)The AI boom continues to snowball with no signs of slowing... Google CEO, Sundar Pichai, made waves during a recent call with analysts, reminding them that the search engine company has been “AI first” since 2016.Get the full story here. MRSN Short Interest - Frequently Asked Questions What is Mersana Therapeutics' current short interest? Short interest is the volume of Mersana Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 10,920,000 shares of MRSN short. Learn More on Mersana Therapeutics' current short interest. What is a good short interest ratio for Mersana Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MRSN shares currently have a short interest ratio of 5.0. Learn More on Mersana Therapeutics's short interest ratio. Is Mersana Therapeutics' short interest increasing or decreasing? Mersana Therapeutics saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 10,920,000 shares, an increase of 3.2% from the previous total of 10,580,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Mersana Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Mersana Therapeutics: Atai Life Sciences (5.43%), Erasca, Inc. (10.23%), Nektar Therapeutics (1.99%), Nkarta, Inc. (14.02%), Kamada Ltd. (0.12%), ADC Therapeutics SA (1.43%), Verastem, Inc. (3.49%), Atea Pharmaceuticals, Inc. (2.43%), UroGen Pharma Ltd. (18.89%), Vanda Pharmaceuticals Inc. (4.17%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Mersana Therapeutics stock? Short selling MRSN is an investing strategy that aims to generate trading profit from Mersana Therapeutics as its price is falling. MRSN shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Mersana Therapeutics? A short squeeze for Mersana Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MRSN, which in turn drives the price of the stock up even further. How often is Mersana Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MRSN, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Atai Life Sciences Short Interest Data Erasca Short Interest Data Nektar Therapeutics Short Interest Data Nkarta Short Interest Data Kamada Short Interest Data ADC Therapeutics Short Interest Data Verastem Short Interest Data Atea Pharmaceuticals Short Interest Data UroGen Pharma Short Interest Data Vanda Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:MRSN) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Crypto 9-5 Escape PlanCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithBuy this small stock before coming AI Tidal WaveChaikin AnalyticsElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap Sniper